欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Cibinqo	Human	abrocitinib	abrocitinib	EMEA/H/C/005452	Pfizer Europe MA EEIG	2021/12/09	Authorised
Sitagliptin SUN	Human	sitagliptin fumarate	sitagliptin fumarate	EMEA/H/C/005741	Sun Pharmaceutical Industries Europe B.V.	2021/12/09	Authorised
Rybrevant	Human	amivantamab	amivantamab	EMEA/H/C/005454	Janssen-Cilag International N.V.	2021/12/09	Authorised
Artesunate Amivas	Human	artesunate	artesunate	EMEA/H/C/005550	Amivas Ireland Ltd	2021/11/22	Authorised
Brukinsa	Human	zanubrutinib	zanubrutinib	EMEA/H/C/004978	BeOne Medicines Ireland Limited	2021/11/22	Authorised
Trodelvy	Human	sacituzumab govitecan	sacituzumab govitecan	EMEA/H/C/005182	Gilead Sciences Ireland UC	2021/11/22	Authorised
Qinlock	Human	ripretinib	ripretinib	EMEA/H/C/005614	Deciphera Pharmaceuticals (Netherlands) B.V.	2021/11/18	Authorised
Gavreto	Human	pralsetinib	pralsetinib	EMEA/H/C/005413	Blueprint Medicines (Netherlands) B.V.	2021/11/18	Withdrawn
Hukyndra	Human	adalimumab	adalimumab	EMEA/H/C/005548	Stada Arzneimittel AG	2021/11/15	Authorised
Sugammadex Mylan	Human	sugammadex	sugammadex sodium	EMEA/H/C/005403	Mylan Pharmaceuticals Limited	2021/11/15	Authorised
Vumerity	Human	diroximel fumarate	Diroximel fumarate (BIIB098)	EMEA/H/C/005437	Biogen Netherlands B.V.	2021/11/15	Authorised
Libmyris	Human	adalimumab	adalimumab	EMEA/H/C/005947	Stada Arzneimittel AG	2021/11/12	Authorised
Ronapreve	Human	casirivimab;imdevimab	casirivimab;imdevimab	EMEA/H/C/005814	Roche Registration GmbH	2021/11/12	Withdrawn
Rivaroxaban Viatris (previously Rivaroxaban Mylan)	Human	rivaroxaban	rivaroxaban	EMEA/H/C/005600	Viatris Limited	2021/11/12	Authorised
Regkirona	Human	regdanvimab	regdanvimab	EMEA/H/C/005854	Celltrion Healthcare Hungary Kft.	2021/11/12	Withdrawn
Imatinib Koanaa	Human	imatinib	imatinib mesilate	EMEA/H/C/005595	Koanaa Healthcare GmbH	2021/09/22	Withdrawn
Ozawade	Human	pitolisant	pitolisant	EMEA/H/C/005117	Bioprojet Pharma	2021/09/01	Authorised
Minjuvi	Human	tafasitamab	tafasitamab	EMEA/H/C/005436	Incyte Biosciences Distribution B.V.	2021/08/26	Authorised
Voxzogo	Human	vosoritide	vosoritide	EMEA/H/C/005475	BioMarin International Limited	2021/08/26	Authorised
Bimzelx	Human	bimekizumab	bimekizumab	EMEA/H/C/005316	UCB Pharma S.A.	2021/08/20	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-